A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

NCT01318421 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Elan Pharmaceuticals